RecruitingNot ApplicableNCT06129903

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

The Effect of Enhanced Behavioral Healthcare on Self-Reported Depression, Anxiety, and Health-Related Quality of Life Among Patients With Musculoskeletal Sarcoma Undergoing Surgery: A Randomized Pilot Study


Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

60 participants

Start Date

Nov 7, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to investigate the feasibility of early access to mental healthcare during sarcoma treatment as well as to assess the association between early access to psychiatric care and depression, anxiety, postoperative outcomes, and patient satisfaction in patients undergoing surgery for musculoskeletal sarcoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is testing whether early referral to psychiatry or psychology (at the time of diagnosis) improves mental health and quality of life for people newly diagnosed with bone or soft tissue sarcoma, compared to receiving mental health support only when needed later in treatment. **You may be eligible if:** - You are 18 or older - You have been diagnosed (or have a high suspicion of diagnosis) with a primary bone or soft tissue sarcoma - You are presenting to the Orthopaedic Surgery Service and plan to have surgery at MSK - You have not been previously treated for sarcoma - You speak English fluently and prefer English for healthcare discussions **You may NOT be eligible if:** - You have a significant pre-existing psychiatric condition that would make study participation unsafe (e.g., severe mental illness, prior psychiatric hospitalizations, or history of suicide attempts) - You are in an urgent or emergency mental health crisis at the time of enrollment Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERreferral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences.

The primary intervention in this study is referral to the Memorial Sloan-Kettering Cancer Center (MSK) Department of Psychiatry and Behavioral Sciences. This study will not dictate specific psychiatry interventions beyond providing the referral.


Locations(8)

Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (All Protocol Activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States

Memorial Sloan Kettering Suffolk-Commack (Limited Protocol Activities )

Commack, New York, United States

Memorial Sloan Kettering Westchester (All Protocol Activities)

Harrison, New York, United States

Memorial Sloan Kettering Cancer Center (All protocol activites)

New York, New York, United States

Memorial Sloan Kettering Nassau (All protocol activities)

Uniondale, New York, United States

William Beaumont Army Medical Center

Fort Bliss, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06129903


Related Trials